Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny. - Nowicki TS; Deen NNA; Peters CW; Comin-Anduix B; Medina E; Puig-Saus C; Carretero IB; Kaplan-Lefko P; Macabali MH; Garcilazo IP; Chen D; Pang J; et al. (Nature communications, 2025)